Adcetris 50 MG Injection
- RxCUI
- 1147327
- RxNorm name
- Adcetris 50 MG Injection
- Display name
- Adcetris 50 MG Injection
- Full name
- Adcetris 50 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125388 | Adcetris | brentuximab vedotin | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADCETRIS | BRENTUXIMAB VEDOTIN | SEAGEN INC. | 3904f8dd-1aef-3490-e48f-bd55f32ed67f | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | 1147327 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3904f8dd-1aef-3490-e48f-bd55f32ed67f | Adcetris 50 MG Injection | PSN | 38 | These highlights do not include all the information needed to use ADCETRIS safely and effectively. See full prescribing information for ADCETRIS. ADCETRIS ® (brentuximab vedotin) for injection, for intravenous use Initial U.S. approval: 2011 | 20251111 |
| 3904f8dd-1aef-3490-e48f-bd55f32ed67f | brentuximab vedotin 50 MG Injection [Adcetris] | SBD | 38 | These highlights do not include all the information needed to use ADCETRIS safely and effectively. See full prescribing information for ADCETRIS. ADCETRIS ® (brentuximab vedotin) for injection, for intravenous use Initial U.S. approval: 2011 | 20251111 |
| 3904f8dd-1aef-3490-e48f-bd55f32ed67f | Adcetris 50 MG Injection | SY | 38 | These highlights do not include all the information needed to use ADCETRIS safely and effectively. See full prescribing information for ADCETRIS. ADCETRIS ® (brentuximab vedotin) for injection, for intravenous use Initial U.S. approval: 2011 | 20251111 |